Blackhawk Growth Corp C.BLR.WT

Blackhawk Submits SARS-CoV-2 IgG / IgM Rapid Test Kit

[etcetera]

Vancouver, British Columbia - TheNewswire - November 9, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the "Corporation" or "Blackhawk"), is pleased to provide the following corporate update.

The Health Canada Interim Order ("IO") application was completed and submitted for its SARS-CoV-2 IgG / IgM Rapid Test Kit.

The extensive application was submitted November 4th and Health Canada confirmed receipt of the application the same day.

Even though Blackhawk cannot guarantee timelines, the anticipated time to process the application is between 40 and 60 days.

The SARS-CoV-2 IgG / IgM Rapid Test Kit currently holds Federal Drug Administration (FDA) Emergency Use Authorization (EUA) as well as a CE Mark in Europe.

https://www.thenewswire.com/press-releases/1LYzFPdZ7-blackhawk-submits-sars-cov-2-igg-igm-rapid-test-kit-interim-order-application-and-provides-update-on-previously-submitted-exprobe-sars-cov-2-testing-kit.html

[moneywinner1]

he SARS-CoV-2 IgG / IgM Rapid Test Kit currently holds Federal Drug Administration (FDA) Emergency Use Authorization (EUA) as well as a CE Mark in Europe.   It is going to go 300-1000%  In Near future   

[moneywinner1]

Ltd see 0.035 this week  he SARS-CoV-2 IgG / IgM Rapid Test Kit currently holds Federal Drug Administration (FDA) Emergency Use Authorization (EUA) as well as a CE Mark in Europe.

[moneywinner1]

News available in your trading platform, but not available in social platforms, likd company said multiple different developments happening in the company and I love today's news and more yo come  Let's see new 52 week high 

[moneywinner1]

News available in your trading platform, but not available in social platforms, likd company said multiple different developments happening in the company and I love today's news and more yo come  Let's see new 52 week high 

[moneywinner1]

Vancouver, British Columbia - TheNewswire - November 9, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the "Corporation" or "Blackhawk"), is pleased to provide the following corporate update. The Health Canada Interim Order ("IO") application was completed and submitted for its SARS-CoV-2 IgG / IgM Rapid Test Kit.  The extensive application was

[moneywinner1]

This will have new 52 week high, more news coming as per company statement, many developments on few fronts 

[moneywinner1]

Vancouver, British Columbia - TheNewswire - November 9, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the "Corporation" or "Blackhawk"), is pleased to provide the following corporate update. The Health Canada Interim Order ("IO") application was completed and submitted for its SARS-CoV-2 IgG / IgM Rapid Test Kit.  The extensive application was

[moneywinner1]

November 13,2020 3 steadies to be finished and let's see new 51 week high 

[moneywinner1]

Bids are at 17,000,000 below 0.02 let's see them moving up , only MM make active trading, it's easy to see this stock is on the way upwards, I'm Going to see new 52 week high over 0.10 , do  the counting of this potential 

[moneywinner1]

The ExProbe SARS-CoV-2 TESTING KIT Interim order application has been progressing. On October 20 2020 we received a request for additional information from Health Canada. The information they were seeking involves 3 studies to be performed, given the complexity of the studies we requested until November 13, 2020 deadline to perform and submit the requested studies. The request was granted and we

[moneywinner1]

This is a 1000% gainer like many did . Love it  The ExProbe SARS-CoV-2 TESTING KIT Interim order application has been progressing. On October 20 2020 we received a request for additional information from Health Canada. The information they were seeking involves 3 studies to be performed, given the complexity of the studies we requested until November 13, 2020 deadline to perform and submit

[moneywinner1]

Be ready for November 13,2020 This is a 1000% gainer like many did . Love it  The ExProbe SARS-CoV-2 TESTING KIT Interim order application has been progressing. On October 20 2020 we received a request for additional information from Health Canada. The information they were seeking involves 3 studies to be performed, given the complexity of the studies we requested until November 13, 2020